| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0009 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |